These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35397391)

  • 1. Emerging roles of Sirtuins in alleviating alcoholic liver Disease: A comprehensive review.
    Zhao X; Xue X; Wang C; Wang J; Peng C; Li Y
    Int Immunopharmacol; 2022 Jul; 108():108712. PubMed ID: 35397391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of necroptosis in alcoholic liver disease and hepatic pathogenesis.
    Zhou Y; Wu R; Wang X; Bao X; Lu C
    Cell Prolif; 2022 Mar; 55(3):e13193. PubMed ID: 35083817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice.
    Kim HG; Huang M; Xin Y; Zhang Y; Zhang X; Wang G; Liu S; Wan J; Ahmadi AR; Sun Z; Liangpunsakul S; Xiong X; Dong XC
    J Hepatol; 2019 Nov; 71(5):960-969. PubMed ID: 31295533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular insights on intracellular Wnt/β-catenin signaling in alcoholic liver disease.
    Shree Harini K; Ezhilarasan D; Mani U
    Cell Biochem Funct; 2024 Jan; 42(1):e3916. PubMed ID: 38269515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of silent information regulator 1-serine/arginine-rich splicing factor 10-lipin 1 axis in the pathogenesis of alcohol fatty liver disease.
    Li Y; Zhou J
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1117-1125. PubMed ID: 28467182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy.
    You Y; Li WZ; Zhang S; Hu B; Li YX; Li HD; Tang HH; Li QW; Guan YY; Liu LX; Bao WL; Shen X
    J Hepatol; 2018 Jul; 69(1):129-141. PubMed ID: 29452206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
    Nagata K; Suzuki H; Sakaguchi S
    J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.
    Sakaguchi S; Takahashi S; Sasaki T; Kumagai T; Nagata K
    Drug Metab Pharmacokinet; 2011; 26(1):30-46. PubMed ID: 21150132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease.
    Yang YM; Cho YE; Hwang S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 in alcoholic liver disease.
    Sun J; Fu J; Li L; Chen C; Wang H; Hou Y; Xu Y; Pi J
    Toxicol Appl Pharmacol; 2018 Oct; 357():62-69. PubMed ID: 30165058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
    Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
    Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
    [No Abstract]   [Full Text] [Related]  

  • 13. The role and therapeutic potential of SIRTs in sepsis.
    You J; Li Y; Chong W
    Front Immunol; 2024; 15():1394925. PubMed ID: 38690282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research progress on Sirtuins (SIRTs) family modulators.
    Chen M; Tan J; Jin Z; Jiang T; Wu J; Yu X
    Biomed Pharmacother; 2024 May; 174():116481. PubMed ID: 38522239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Roles of SIRT1 in Alcoholic Liver Disease.
    Ren R; Wang Z; Wu M; Wang H
    Int J Biol Sci; 2020; 16(16):3174-3183. PubMed ID: 33162823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
    Mukhopadhyay P; Horváth B; Rajesh M; Varga ZV; Gariani K; Ryu D; Cao Z; Holovac E; Park O; Zhou Z; Xu MJ; Wang W; Godlewski G; Paloczi J; Nemeth BT; Persidsky Y; Liaudet L; Haskó G; Bai P; Boulares AH; Auwerx J; Gao B; Pacher P
    J Hepatol; 2017 Mar; 66(3):589-600. PubMed ID: 27984176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steatosis in metabolic diseases: A focus on lipolysis and lipophagy.
    Zhao X; Amevor FK; Cui Z; Wan Y; Xue X; Peng C; Li Y
    Biomed Pharmacother; 2023 Apr; 160():114311. PubMed ID: 36764133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes.
    Lu C; Zhang F; Xu W; Wu X; Lian N; Jin H; Chen Q; Chen L; Shao J; Wu L; Lu Y; Zheng S
    IUBMB Life; 2015 Aug; 67(8):645-58. PubMed ID: 26305715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.
    Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML
    Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyl ferulic acid attenuates ethanol-induced hepatic steatosis by regulating AMPK and FoxO1 Pathways in Rats and L-02 cells.
    Cheng Q; Li YW; Yang CF; Zhong YJ; He H; Zhu FC; Li L
    Chem Biol Interact; 2018 Aug; 291():180-189. PubMed ID: 29940154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.